Stay updated on Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Sign up to get notified when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.
Latest updates to the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction while removing extensive options related to participant groups, interventions, and various data fields for downloads.SummaryDifference2%
- Check35 days agoChange DetectedSeveral links related to rare diseases and clinical trials have been removed, including those for renal cell carcinoma and specific drug information.SummaryDifference0.3%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with new additions including links to rare disease information, clinical trial documents, and drug information for Bevacizumab and Pembrolizumab.SummaryDifference3%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: MK-3475 Combo in Renal Cell Carcinoma page.